Merck aims to hike revenues in China to 1 billion euro by 2018

Sat Jul 26, 2014 7:48am EDT
 
Email This Article |
Share This Article
  • Facebook
  • LinkedIn
  • Twitter
| Print This Article
[-] Text [+]

FRANKFURT (Reuters) - Merck (MRCG.DE: Quote) will start offering non-prescription drugs in China as part of a push to double revenues in the region to 1 billion euros ($1.3 billion) by 2018, Chief Executive Karl-Ludwig Kley told German weekly Wirtschaftswoche.

Merck will focus on treatments related to diabetes, thyroid issues and heart problems, and supply medication made at a new factory in Nantong which is due to start production in 2017, Wirtschaftswoche said.

($1 = 0.7447 Euros)

(Reporting by Edward Taylor; Editing by Ruth Pitchford)

 
A branch of drugs and chemicals group Merck is pictured in central German city of Darmstadt March 7, 2012. REUTERS/Alex Domanski